Another study demonstrated that women with PCOS and NAFLD had decreased hepatic LDL receptor expression, and hypothesized that hyperandrogenism may putwomen with PCOS at risk for development of dyslipidemia and NAFLD [45]. This evidence concerns the gene LDLR and metabolic syndrome.